IGC Pharma (IGC) Assets (2011 - 2026)
IGC Pharma (IGC) posted quarterly Assets of $9.2 million for Q1 2026, up 5.01% year-over-year from $8.7 million in Q1 2025, and down 5.43% quarter-over-quarter from $9.7 million in Q4 2025.
IGC Pharma (IGC) Assets (2011 - 2026) Analysis & Trends
IGC Pharma (IGC) has reported Assets for 16 consecutive years, with $9.2 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Assets rose 5.01% year-over-year to $9.2 million; the TTM figure through Mar 2026 stood at $9.2 million (up 5.01% YoY), while the FY2026 annual figure was $9.2 million, up 5.01% from the prior year.
- Assets slipped to $9.2 million in Q1 2026 per IGC's latest filing, from $9.7 million in the prior quarter.
- Across five years, Assets topped out at $26.8 million in Q1 2022 and bottomed at $7.9 million in Q2 2025.
- Historically, Assets has averaged $14.1 million across 5 years, with a median of $10.6 million in 2024.
- Annual changes were most pronounced in 2023 — Assets plunged 43.9% — and 2025, when it gained 6.98%.
- IGC Pharma's Assets stood at $20.1 million in 2022, then slumped by 43.9% to $11.3 million in 2023, then fell by 19.37% to $9.1 million in 2024, then climbed by 6.98% to $9.7 million in 2025, then decreased by 5.43% to $9.2 million in 2026.
- Business Quant data shows IGC's Assets at $9.2 million in Q1 2026, $9.7 million in Q4 2025, and $9.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 27.42 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 41.73 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 10.03 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 10.96 Bn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 9.18 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 5.56 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 2.10 Bn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 19.82 Bn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 25.60 Bn |
| 10 | IGC Pharma | 27.20 Mn | 26.94 Mn | - | 9.19 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.19 Mn |
| Dec 31, 2025 | 9.71 Mn |
| Sep 30, 2025 | 9.74 Mn |
| Jun 30, 2025 | 7.94 Mn |
| Mar 31, 2025 | 8.75 Mn |
| Dec 31, 2024 | 9.08 Mn |
| Sep 30, 2024 | 10.37 Mn |
| Jun 30, 2024 | 10.59 Mn |
| Mar 31, 2024 | 9.90 Mn |
| Dec 31, 2023 | 11.26 Mn |
| Sep 30, 2023 | 16.51 Mn |
| Jun 30, 2023 | 15.67 Mn |
| Mar 31, 2023 | 17.18 Mn |
| Dec 31, 2022 | 20.07 Mn |
| Sep 30, 2022 | 21.96 Mn |
| Jun 30, 2022 | 24.17 Mn |
| Mar 31, 2022 | 26.83 Mn |
| Dec 31, 2021 | 31.29 Mn |
| Sep 30, 2021 | 33.84 Mn |
| Jun 30, 2021 | 34.44 Mn |